Logo image of INFU

INFUSYSTEM HOLDINGS INC (INFU) Stock Price, Forecast & Analysis

USA - NYSEARCA:INFU - US45685K1025 - Common Stock

10 USD
+0.54 (+5.71%)
Last: 11/5/2025, 8:04:00 PM
9.5 USD
-0.5 (-5%)
After Hours: 11/5/2025, 8:04:00 PM

INFU Key Statistics, Chart & Performance

Key Statistics
Market Cap204.30M
Revenue(TTM)134.86M
Net Income(TTM)5.07M
Shares20.43M
Float18.99M
52 Week High11.04
52 Week Low4.61
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.26
PE38.46
Fwd PE25.58
Earnings (Next)03-02 2026-03-02/bmo
IPO2006-06-15
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services


INFU short term performance overview.The bars show the price performance of INFU in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60 80

INFU long term performance overview.The bars show the price performance of INFU in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 5 10 15 20 25

The current stock price of INFU is 10 USD. In the past month the price increased by 1.83%. In the past year, price increased by 28.04%.

INFUSYSTEM HOLDINGS INC / INFU Daily stock chart

INFU Latest News, Press Relases and Analysis

INFU Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CVS CVS HEALTH CORP 11.47 99.63B
CI THE CIGNA GROUP 9.14 69.29B
LH LABCORP HOLDINGS INC 15.85 20.83B
DGX QUEST DIAGNOSTICS INC 18.26 19.93B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 110.18 19.91B
FMS FRESENIUS MEDICAL CARE-ADR 13.11 14.23B
GH GUARDANT HEALTH INC N/A 11.85B
HIMS HIMS & HERS HEALTH INC 76.72 9.88B
DVA DAVITA INC 13.13 8.66B
CHE CHEMED CORP 19.95 6.40B
RDNT RADNET INC 217.03 6.01B
BTSG BRIGHTSPRING HEALTH SERVICES 32.04 5.79B

About INFU

Company Profile

INFU logo image InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 502 full-time employees. The company went IPO on 2006-06-15. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.

Company Info

INFUSYSTEM HOLDINGS INC

3851 West Hamlin Road

Rochester Hills MICHIGAN 48309 US

CEO: Richard DiIorio

Employees: 508

INFU Company Website

INFU Investor Relations

Phone: 12482911210

INFUSYSTEM HOLDINGS INC / INFU FAQ

Can you describe the business of INFUSYSTEM HOLDINGS INC?

InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 502 full-time employees. The company went IPO on 2006-06-15. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.


Can you provide the latest stock price for INFUSYSTEM HOLDINGS INC?

The current stock price of INFU is 10 USD. The price increased by 5.71% in the last trading session.


Does INFUSYSTEM HOLDINGS INC pay dividends?

INFU does not pay a dividend.


How is the ChartMill rating for INFUSYSTEM HOLDINGS INC?

INFU has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


How is the market expecting INFU stock to perform?

11 analysts have analysed INFU and the average price target is 14.03 USD. This implies a price increase of 40.25% is expected in the next year compared to the current price of 10.


What sector and industry does INFUSYSTEM HOLDINGS INC belong to?

INFUSYSTEM HOLDINGS INC (INFU) operates in the Health Care sector and the Health Care Providers & Services industry.


Is INFUSYSTEM HOLDINGS INC (INFU) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on INFU.


INFU Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to INFU. When comparing the yearly performance of all stocks, INFU is one of the better performing stocks in the market, outperforming 83.85% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

INFU Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to INFU. Both the health and profitability get an excellent rating, making INFU a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

INFU Financial Highlights

Over the last trailing twelve months INFU reported a non-GAAP Earnings per Share(EPS) of 0.26. The EPS increased by 333.33% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.63%
ROA 5.03%
ROE 9.3%
Debt/Equity 0.48
Chartmill High Growth Momentum
EPS Q2Q%37.5%
Sales Q2Q%3.31%
EPS 1Y (TTM)333.33%
Revenue 1Y (TTM)7.22%

INFU Forecast & Estimates

11 analysts have analysed INFU and the average price target is 14.03 USD. This implies a price increase of 40.25% is expected in the next year compared to the current price of 10.

For the next year, analysts expect an EPS growth of 165.2% and a revenue growth 6.04% for INFU


Analysts
Analysts83.64
Price Target14.03 (40.3%)
EPS Next Y165.2%
Revenue Next Year6.04%

INFU Ownership

Ownership
Inst Owners75.26%
Ins Owners4.59%
Short Float %0.77%
Short Ratio0.58